Exponent Reports Second Quarter 2026 Financial Results

Exponent posts double-digit revenue and earnings growth, with robust capital returns to shareholders.

What the company is saying

Exponent, Inc. presents its second quarter 2026 results as evidence of sustained, broad-based demand, emphasizing double-digit growth in both revenues and earnings. The narrative highlights 'continued demand for our specialized expertise across industries' and frames the quarter as 'another strong' period, with the tone remaining confident and positive. The company foregrounds its capital return activities, specifying $31.3 million in dividends paid and $146.1 million in stock repurchases, and announces a $50 million increase in the repurchase program. Segment performance is broken out, with the engineering and other scientific segment comprising 85% of revenues before reimbursements, and the environmental and health segment 15%. Forward-looking statements are included, projecting 8–10% revenue growth in the next quarter and 9–10% for the full year, with EBITDA margins expected to remain near 28%. Claims about specific growth drivers, such as AI-enabled product research and utility sector work, are asserted but not quantified. The messaging is assertive, with leadership (Dr. Catherine Corrigan, CEO, and Eric Anderson, CFO) cited as sources of confidence, but without overreliance on hype or unsupported projections.

What the data suggests

The reported numbers show a clear upward trajectory: total revenues for Q2 2026 rose 21% year-over-year to $171.6 million, and revenues before reimbursements increased 12% to $148.9 million. Net income improved to $29.4 million, or $0.60 per diluted share, up from $26.6 million and $0.52, respectively, in the prior year quarter. EBITDA margin expanded to 28.7% of revenues before reimbursements, compared to 27.8% a year ago. For the first half of 2026, total revenues climbed 18% to $337.9 million, and net income reached $59.0 million, or $1.19 per diluted share. Cash and cash equivalents at period end were $66.6 million, after $31.3 million in dividends and $146.1 million in share repurchases. Segment data is consistent: engineering and other scientific grew 13% in Q2 and 12% in H1, while environmental and health grew 9% and 5%, respectively. Utilization was strong at 74%. The data is comprehensive for headline financials, but lacks detail on the specific service lines or industries that drove growth, making it impossible to independently verify claims about AI, utilities, or dispute work.

Analysis

The announcement's tone is positive but proportionate to the actual, measurable financial progress disclosed. The company reports double-digit growth in both revenues and net income, with EBITDA and margin improvements, all supported by specific numerical data. Forward-looking statements (such as revenue and EBITDA guidance) are present but are a minority of the key claims, and the majority of the announcement focuses on realised, audited results. There is no evidence of narrative inflation: the language describing growth is substantiated by the reported numbers, and there are no exaggerated claims about future potential without basis. Capital return activities (dividends, buybacks) are disclosed as completed actions, not as aspirational plans. No large capital outlay is paired with long-dated, uncertain returns.

Risk flags

• ●Narrative claims about growth drivers—such as AI-enabled product research and utility sector engagements—are not supported by segment-level or service-line financial data, limiting the ability to assess the sustainability or concentration of growth. This matters because investors cannot independently verify whether growth is broad-based or reliant on a few sectors.
• ●Capital returns are significant, with $146.1 million in repurchases and $31.3 million in dividends in the first half, but cash and cash equivalents at period end are $66.6 million. While not alarming, this level of cash relative to capital return pace could constrain flexibility if earnings growth slows or working capital needs rise.
• ●Forward guidance for 8–10% revenue growth and 28% EBITDA margins is credible given recent performance, but no reconciliation of non-GAAP to GAAP measures is provided for these projections. This lack of transparency in forward-looking metrics could obscure underlying risks or adjustments.

Bottom line

Exponent’s Q2 2026 results show robust, realized growth in revenues and earnings, with strong capital returns to shareholders through dividends and buybacks. The company’s headline financials are well-supported by the disclosed data, and forward guidance for continued growth and stable margins appears realistic given recent trends. However, the lack of granular disclosure on the sources of growth—particularly for narrative claims about AI, utilities, and dispute work—limits visibility into the durability or concentration of performance. The capital return pace is high relative to cash on hand, which could become a constraint if growth moderates. For investors, the most important takeaway is that Exponent is delivering on its core financial metrics, but more detailed segment or service-line reporting would be needed to fully assess the sustainability of its growth drivers.

Announcement summary

(NASDAQ:EXPO) Exponent, Inc. reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026, with total revenues increasing 21% to $171.6 million and revenues before reimbursements rising 12% to $148.9 million compared to the second quarter of 2025. Net income for the quarter increased to $29.4 million, or $0.60 per diluted share, up from $26.6 million, or $0.52 per diluted share, in the same period of 2025. EBITDA increased to $42.7 million, or 28.7% of revenues before reimbursements, compared to $37.0 million, or 27.8% in the prior year quarter. For the first half of 2026, total revenues rose 18% to $337.9 million and revenues before reimbursements grew 11% to $300.7 million, with net income reaching $59.0 million, or $1.19 per diluted share. Exponent paid $31.3 million in dividends, repurchased $146.1 million of common stock, and ended the period with $66.6 million in cash and cash equivalents. The company announced a quarterly cash dividend of $0.31 to be paid on September 18, 2026, and the Board approved a $50 million increase in the stock repurchase program. Exponent anticipates revenues before reimbursements to grow 8% to 10% in the third quarter of 2026 and 9% to 10% for the full fiscal year, with EBITDA expected to be 28.0% to 28.5% and 27.8% to 28.1% of revenues before reimbursements, respectively.

Disagree with this article?